個案報告及文獻回顧:睪丸間質細胞瘤
陳致豪、劉建良、黃冠華
奇美醫學中心 外科部 泌尿科
 
TESTICULAR LEYDIG CELL TUMOR:
A CASE REPORT & REVIEW OF LITERATURE
Zhi-Hao Chen, Chien-Liang Liu, Steven Kuan-Hua Huang
Divisions of Urology, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan
 
Introduction:
Leydig cell tumor are rare testicular tumor. Most of them are benign, but sometimes malignant. Leydig cell tumor had poor response to medical therapy, such as chemotherapy and radiotherapy. We described a case of left scrotal mass. The patient underwent radical orchiectomy and the pathology report showed a rare diagnosis of Leydig cell tumor.
 
Case report:
A 39-year-old male found himself to have left scrotal firm mass for 3 weeks. He went to our outpatient department for help. Physical examination showed left scrotal firm and painless mass. Tumor markers (β-HCG and AFP) were within normal limit. Scrotal sonography showed a well-defined isoechoic mass in the left testis, about 3.3 x 2.9 x 3.5 cm with internal vascularity. Left radical orchiectomy was performed smoothly. Operative findings showed hardening of the left testis about 4cm in size, with intact tunica albuginea. Pathology report showed a yellow soft tumor with capsule, locating at the center of testis, measuring 3.2 x 3 x 2.6 cm, composed of neoplastic cells forming large nodules separated by collagenous stroma, with focal ribbon-liked, and microcystic pattern. Leydig cell tumor was confirmed. The patient had stable condition after the operation and discharged smoothly on POD 2.
 
Conclusion:
Medical treatment plays little role on Leydig cell tumor. Some literature revealed the possibility of testis-sparing orchiectomy. Main surgical choice is still radical orchiectomy, which could have correct diagnosis and have good prognosis.
    位置
    資料夾名稱
    摘要
    發表人
    TUA秘書處
    單位
    台灣泌尿科醫學會
    建立
    2017-12-25 17:03:28
    最近修訂
    2017-12-25 20:49:13
    1. 1.
      Podium
    2. 2.
      Moderated Poster
    3. 3.
      Non-Discussion Poster